Discovery of FK453, a novel non-xanthine adenosine A1 receptor antagonist

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 17, 1996, Pages 2059-2062

  Akahane, Atsushi ^a   Katayama, Hirohito ^a   Mitsunaga, Takafumi ^a   Kita, Yasuhiro ^a   Kusunoki, Takahiro ^a   Terai, Takao ^a   Yoshida, Keizo ^a   Shiokawa, Youichi ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 HYDROXYETHYL) 1 [3 (2 PHENYLPYRAZOLO[1,5 A]PYRIDIN 3 YL)ACRYLOYL]PIPERIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; BAY N 1468; CYCLOHEXYLADENOSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DIURESIS; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GUINEA PIG; HEART ATRIUM; INOTROPISM; NONHUMAN; ORAL DRUG ADMINISTRATION; PHOTOCHEMISTRY; RAT;

EID: 0030567864     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00368-X     Document Type: Article

References (22)

1. Adenosine and Adenosine Receptors; Williams, M., Ed.; Humana Press: Clifton, New Jersey, 1990; pp 1-15.
2. Williams, M. Med. Res. Rev. 1989, 9, 219.
3. Dalziel, H. H.; Westfall, D. P. Pharmacol. Rev. 1994, 46, 449.
4. Jacobson, K. A.; van Galen, P. J. M.; Williams, M. J. Med. Chem. 1992, 55, 407.
5. Bruns, R. F.; Fergus, J. H.; Badger, E. W.; Bristol, J. A.; Stantay, L. A.; Hartman, J. D.; Hays, S. J.; Huang, C.C. Arch. Pharmacol. 1987, 335, 59.
6. Martinson, E. A.; Johnson, R. A.; Wells, J. N., Mol. Pharmacol. 1987, 31, 247.
7. Schingnitz, G.; Këfner-Mühl, U.; Ensinger, H.; Lehr, E.; Kuhn, F. J. Nucleosides Nucleotides 1991, 10, 1067
8. Shimada, J.; Suzuki, F.; Nonaka, H.; Karasawa, A.; Mizumoto, H.; Ohno, T.; Kubo, K.; Ishii, A. J. Med. Chem. 1991, 354, 466.
9. Collis, M. G.; Shaw, G.; Keddie, J. R. J. Pharm. Pharmacol. 1991, 43, 138.
10. Meyer, H.; Hortsmann, H.; Moller, E.; Garthoff, B. European Patent 412215 (1981) Chem. Abstr., 96: 122803.
11. Terai, T.; Kita, Y.; Kusunoki, T.; Andoh, T.; Shimazaki, T.; Deguchi, Y.; Akahane, A.; Shiokawa, Y.; Yoshida, K. Eur. J. Pharmacol. 1990, 183, 1057.
12. Terai, T.; Kita, Y.; Kusunoki, T.; Andoh, T.; Nagatomi, I.; Horiai, H.; Akahane, A.; Shiokawa, Y.; Yoshida, K. Drug Dev. Res. 1995, 36, 25.
13. Terai, T.; Kita, Y.; Kusunoki, T.; Shimazaki, T.; Andoh, T.; Horiai, H.; Akahane, A.; Shiokawa, Y.; Yoshida, K. Eur. J. Pharmacol. 1995, 279, 217.
14. Anderson, P. L.; Hasak, J. P.; Kahle, A. D. J. Heterocycl. Chem. 1981, 18, 1149.
15. D+ 39.6 (c = 1.04, 95% EtOH).
16. Ripperger, H.; Schreiber, K.; Sych, F. -J. J. Prakt. Chem. 1970, 312, 471.
17. Toy, M. S.; Price, C. C. J. Am. Chem. Soc. 1960, 82, 2613.
18. 2, and an equilibrium mixture (trans : cis = ca. 1 : 5.3) is eventually formed. However, no photoisomerization of FK453 was observed in plasma after oral administration.
19. Takeda, M.; Yoshitomi, K.; Imai, M. Am. J. Physiol 1993, 265, f511.
20. Kohno, Y.; Horiai, H.; Yamamoto, K.; Esumi, K.; Andoh, T.; Mori, J. Jpn. J. Pharmacol. 1993, 61, suppl. 172p.
21. van Buren, M.; Bijlsma, J. A.; Boer, P.; van Rijn, H. J. M.; Koomans, H. A. Hypertension 1993, 22, 728.
22. Balakrishnan, V. S.; von Ruhland, C. J.; Griffiths, D. F. R.; Coles, G. A., Williams, J. D. Br. J. Pharmacol. 1996, 117, 879.